United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - chlortalidone - oral tablet - 50mg

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - chlortalidone 25mg; potassium chloride 500mg - tablet - 25mg/500mg - active: chlortalidone 25mg potassium chloride 500mg

Malta - English - Medicines Authority

astrazeneca uk limited - chlortalidone; atenolol - film-coated tablet - chlortalidone 25 mg; atenolol 100 mg - beta blocking agents

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

minophagen pharmaceutical co. - monoammonium glycyrrhizinate (glycyrrhizic acid), glycine, l-cysteine hydrochloride hydrate (l-cysteine hydrochloride) - solution for injection - 53mg/20ml(40mg/20ml)+400mg/20ml+22,29mg/20ml (20mg/20ml)

Malta - English - Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - chlortalidone, atenolol - film-coated tablet - chlortalidone 25 mg atenolol 100 mg - beta blocking agents

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

minophagen pharmaceutical co. - monoammonium glycyrrhizinate (glycyrrhizic acid), glycine, l-cysteine hydrochloride hydrate (l-cysteine hydrochloride) - solution for injection - 53mg/20ml(40mg/20ml)+400mg/20ml+22,29mg/20ml (20mg/20ml)

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

minophagen pharmaceutical co. - monoammonium glycyrrhizinate (glycyrrhizic acid), glycine, l-cysteine hydrochloride hydrate (l-cysteine hydrochloride) - solution for injection - 53mg/20ml(40mg/20ml)+ 400mg/20ml+ 22,29mg/20ml (20mg/20ml)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - chlortalidone - oral tablet - 12.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - chlortalidone - oral tablet - 50mg

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - chlortalidone 25mg;   - tablet - 25 mg - active: chlortalidone 25mg   excipient: colloidal silicon dioxide iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch purified talc - arterial hypertension, essential or nephrogenic or isolated systolic, as primary therapy or in combination with other antihypertensive agents. stable, chronic heart failure of mild to moderate degree (new york heart association, nhya: functional class ii or iii). - oedema of specific origin - oedema due to peripheral (chronic) venous insufficiency; short-term therapy if physical measures prove insufficient. - fluid retention in premenstrual syndrome only if the gain in weight is the main symptom and is well documented. - ascites due to cirrhosis of the liver in stable patients under close control. - oedema due to nephrotic syndrome. - prophylaxis against recurrent calcium oxalate calculi in patients with idiopathic, normocalcaemic hypercalciuria.